December 4, 2025BMJ Neurology OpenOpen Access

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy

View Full Paper

Ask AI

Bookmark

Authors

KAKatja AhinkoTampere University of Applied Sciences

Discussion

Member takes

Implication

Analysis shows biomarker associations and inflammatory response in menopausal women with multiple sclerosis, indicating hormone therapy effects may improve care.

Key Points

Adipokine imbalance linked to systemic inflammation and disease severity in menopausal women with MS, highlighting its importance for disease monitoring.
Body mass index and specific adipokines correlated with inflammatory markers, including tumour necrosis factor and high-sensitivity C reactive protein.
This observational analysis monitored adipokine levels and inflammation during hormone therapy over one year in participants with MS and age-matched controls.
Findings support personalized care approaches through multibiomarker profiling in menopausal women affected by multiple sclerosis.

Cite This Study

Katja Ahinko (2025) studied this question.

synapsesocial.com/papers/6930dc78ea1aef094cca2352 https://doi.org/10.1136/bmjno-2025-001295

View Full Paper

Ask AI

Bookmark

Implication

Analysis shows biomarker associations and inflammatory response in menopausal women with multiple sclerosis, indicating hormone therapy effects may improve care.

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider